Should We Pretreat Before We Go Nuts? Antihistamines Modestly Reduce the Side Effects of Peanut Oral Immunotherapy.
作者信息
Wright Benjamin L
机构信息
Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, Ariz; Section of Allergy and Immunology, Division of Pulmonology, Phoenix Children's Hospital, Phoenix, Ariz.
出版信息
J Allergy Clin Immunol Pract. 2022 Sep;10(9):2395-2396. doi: 10.1016/j.jaip.2022.06.015.
Abstract
摘要
相似文献
1
Should We Pretreat Before We Go Nuts? Antihistamines Modestly Reduce the Side Effects of Peanut Oral Immunotherapy.在我们疯狂之前是否应该进行预处理？抗组胺药可适度降低花生口服免疫疗法的副作用。
J Allergy Clin Immunol Pract. 2022 Sep;10(9):2395-2396. doi: 10.1016/j.jaip.2022.06.015.
2
Peanut Oral Immunotherapy With or Without H and H Antihistamine Premedication for Peanut Allergy (PISCES): A Placebo-Controlled Randomized Clinical Trial.花生口服免疫治疗联合或不联合 H 和 H 抗组胺药预处理治疗花生过敏（PISCES）：一项安慰剂对照随机临床试验。
J Allergy Clin Immunol Pract. 2022 Sep;10(9):2386-2394. doi: 10.1016/j.jaip.2022.05.015. Epub 2022 May 25.
3
Modified peanut oral immunotherapy protocol safely and effectively induces desensitization.改良花生口服免疫疗法方案可安全有效地诱导脱敏。
J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):433-5.e1-3. doi: 10.1016/j.jaip.2014.11.020. Epub 2015 Jan 16.
4
Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial.青少年花生口服免疫疗法：一项随机对照试验的研究方案
Trials. 2015 Apr 29;16:197. doi: 10.1186/s13063-015-0717-y.
5
BSACI guideline for the diagnosis and management of peanut and tree nut allergy.BSACI 花生和树坚果过敏诊断与管理指南。
Clin Exp Allergy. 2017 Jun;47(6):719-739. doi: 10.1111/cea.12957.
6
Oral immunotherapy for treatment of peanut allergy.口服免疫疗法治疗花生过敏。
J Investig Med. 2020 Aug;68(6):1152-1155. doi: 10.1136/jim-2020-001422. Epub 2020 Jul 14.
7
Peanut allergy and oral immunotherapy.花生过敏与口服免疫治疗。
Hong Kong Med J. 2019 Jun;25(3):228-234. doi: 10.12809/hkmj187743. Epub 2019 Jun 10.
8
The evolution of oral immunotherapy for the treatment of peanut allergy.用于治疗花生过敏的口服免疫疗法的发展历程。
Clin Exp Allergy. 2011 Sep;41(9):1172-4. doi: 10.1111/j.1365-2222.2011.03737.x.
9
Correlation of negative skin-prick test results for tree nuts and successful tree nut challenges among children with peanut allergy.对花生过敏儿童进行坚果皮肤点刺试验结果为阴性与坚果激发试验成功之间的相关性。
Allergy Asthma Proc. 2018 Nov 1;39(6):456-460. doi: 10.2500/aap.2018.39.4174.
10
Household almond and peanut consumption is related to the development of sensitization in young children.家庭中杏仁和花生的食用与幼儿过敏致敏的发展有关。
J Allergy Clin Immunol. 2016 Apr;137(4):1248-1251.e6. doi: 10.1016/j.jaci.2015.09.006. Epub 2015 Oct 28.
本文引用的文献
1
Peanut Oral Immunotherapy With or Without H and H Antihistamine Premedication for Peanut Allergy (PISCES): A Placebo-Controlled Randomized Clinical Trial.花生口服免疫治疗联合或不联合 H 和 H 抗组胺药预处理治疗花生过敏（PISCES）：一项安慰剂对照随机临床试验。
J Allergy Clin Immunol Pract. 2022 Sep;10(9):2386-2394. doi: 10.1016/j.jaip.2022.05.015. Epub 2022 May 25.
2
Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.益生菌花生口服免疫治疗与口服免疫治疗和安慰剂在澳大利亚花生过敏儿童中的比较（PPOIT-003）：一项多中心、随机、2b 期试验。
Lancet Child Adolesc Health. 2022 Mar;6(3):171-184. doi: 10.1016/S2352-4642(22)00006-2. Epub 2022 Feb 4.
3
The use of biologics in food allergy.生物制剂在食物过敏中的应用。
Clin Exp Allergy. 2021 Aug;51(8):1006-1018. doi: 10.1111/cea.13897. Epub 2021 Jun 2.
4
Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.花生口服免疫治疗的纵向随机试验中的胃肠道嗜酸性粒细胞反应。
Clin Gastroenterol Hepatol. 2021 Jun;19(6):1151-1159.e14. doi: 10.1016/j.cgh.2020.05.019. Epub 2020 May 17.
5
Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER).口服免疫疗法诱导的胃肠道症状和嗜酸性粒细胞反应的风险因素及治疗结果（OITIGER）
J Allergy Clin Immunol Pract. 2020 Jan;8(1):125-131. doi: 10.1016/j.jaip.2019.07.034. Epub 2019 Aug 2.
6
Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: A randomized controlled study.睡眠剥夺和运动对成人花生过敏反应阈值的影响：一项随机对照研究。
J Allergy Clin Immunol. 2019 Dec;144(6):1584-1594.e2. doi: 10.1016/j.jaci.2019.06.038. Epub 2019 Jul 15.
7
Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.口服免疫疗法治疗花生过敏（PACE）：疗效和安全性的系统评价和荟萃分析。
Lancet. 2019 Jun 1;393(10187):2222-2232. doi: 10.1016/S0140-6736(19)30420-9. Epub 2019 Apr 25.
8
AR101 Oral Immunotherapy for Peanut Allergy.AR101 口服免疫疗法治疗花生过敏。
N Engl J Med. 2018 Nov 22;379(21):1991-2001. doi: 10.1056/NEJMoa1812856. Epub 2018 Nov 18.
9
Effect of ketotifen premedication on adverse reactions during peanut oral immunotherapy.酮替芬预处理对花生口服免疫治疗中不良反应的影响。
Allergy Asthma Clin Immunol. 2014 Jul 9;10(1):36. doi: 10.1186/1710-1492-10-36. eCollection 2014.
10
New efficacy of LTRAs (montelukast sodium): it possibly prevents food-induced abdominal symptoms during oral immunotherapy.LTRAs（孟鲁司特钠）的新疗效：它可能预防口服免疫治疗期间食物诱发的腹部症状。
Allergy Asthma Clin Immunol. 2014 Jan 17;10(1):3. doi: 10.1186/1710-1492-10-3.
Zotero 插件